Novartis | NOVN - Market Capitalization

Stock Price
116.78
Daily Change
0.10 0.09%
Monthly
-1.22%
Yearly
27.56%
Q2 Forecast
114.36

Novartis reported $239.91B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Alcon AG USD 24.12B 12.94B May/2026
Almirall EUR 2.51B 251.72M May/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Autolus Therapeutics Ltd USD 529.63M 0 May/2026
Bayer EUR 37.69B 1.01B May/2026
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Fresenius EUR 22.59B 5B May/2026
Fresenius Medical Care EUR 10.89B 429.56M May/2026
Genmab DKK 20.48B 1.02B Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
GRIFOLS EUR 3.69B 1.9B May/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
J&J USD 579.15B 78.91B Mar/2026
Lakefront Biotherapeutics EUR 1.58B 147.61M May/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 52.48B 826.08M May/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 232.75B 75B May/2026
Novo Nordisk A/S DKK 1.45T 421.31B May/2026
Orion EUR 9.83B 890.75M Mar/2026
Pfizer USD 147.4B 6.42B May/2026
Philips EUR 21.43B 1.05B May/2026
Recordati EUR 10.41B 261.71M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
UCB EUR 46.41B 13.94B Dec/2025